Whole-genome sequencing Archives - Page 27 of 29 - Inside Precision Medicine

Inside Precision Medicine Mining Whole Exome Sequencing Data for Better Cancer Therapies

Whole exome sequencing is becoming more available to patients and will help them distill the sequencing data to candidate genes and link them with therapies. [NCI]

Molecular Dx

Mining Whole Exome Sequencing Data for Better Cancer Therapies

March 30, 2016

TSRI and JCVI scientists conclude that the process of reprogramming is unlikely to introduce variants that would make the cells appropriate for therapy. [Source: iStock/© Archeophoto]

News & Features

Whole-Genome Study Allays Cancer Fears Surrounding Stem Cell Techniques

February 22, 2016

Illustration of DNA double helix on a futuristic blue background

Molecular Dx

Whole Exome Sequencing Wins Blue Ribbon

January 5, 2016

Clinical OMICs Magazine Volume 3, Issue No. 1

News & Features

Clinical OMICs Magazine Volume 3, Issue No. 1

January 1, 2016

The Genome in a Bottle Consortium has developed the world’s first well-characterized whole human genome reference material. [Genome in a Bottle Consortium]

Molecular Dx

Pure Innovation Drives Clinical-Grade NGS

Ian Clift, PhD

October 1, 2015

Clinical OMICs Magazine Volume 2, Issue No. 3

News & Features

Clinical OMICs Magazine Volume 2, Issue No. 3

March 1, 2015

Genomic rearrangements may result in stable

Molecular Dx

Pancreatic Cancer Has Four Genomically Distinct Subtypes

February 26, 2015

Source: © drizzd/Fotolia

Molecular Dx

Taking Whole Genome Sequencing into Prime Time Clinical Practice

February 12, 2015

A collaborative team of scientists have developed a new whole-genome sequencing technique to detect spontaneous mutations in IVF embryos. [3dmentat/Fotolia]

Molecular Dx

Whole-Genome Sequencing Now Possible for IVF

February 12, 2015

Clinical OMICs Magazine Volume 2, Issue No. 2

News & Features

Clinical OMICs Magazine Volume 2, Issue No. 2

February 1, 2015

1...262728 29 Page 27 of 29

Related Content

Questions Raised over Opioid Use Disorder Algorithm

Questions Raised over Opioid Use Disorder Algorithm

Study Highlights Dual Role of CDKN2A Mutations in Esophageal Carcinoma Progression

Study Highlights Dual Role of CDKN2A Mutations in Esophageal Carcinoma Progression

Mayo Clinic, Ambry Genetics Functionally Map 99% of all BRCA2 Hotspot SNVs

Mayo Clinic, Ambry Genetics Functionally Map 99% of all BRCA2 Hotspot SNVs

Treating All the Not-So-Rare “Rare Disease” Patients at Major Care Centers

Treating All the Not-So-Rare “Rare Disease” Patients at Major Care Centers